A detailed history of Mitchell Sinkler & Starr transactions in Merck & Co., Inc. stock. As of the latest transaction made, Mitchell Sinkler & Starr holds 102,289 shares of MRK stock, worth $11.2 Million. This represents 3.28% of its overall portfolio holdings.

Number of Shares
102,289
Previous 107,506 4.85%
Holding current value
$11.2 Million
Previous $14.2 Million 10.73%
% of portfolio
3.28%
Previous 3.56%

Shares

24 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 07, 2024

SELL
$123.8 - $132.96 $645,864 - $693,652
-5,217 Reduced 4.85%
102,289 $12.7 Million
Q1 2024

Apr 30, 2024

SELL
$113.24 - $131.95 $11.4 Million - $13.3 Million
-100,701 Reduced 48.37%
107,506 $14.2 Million
Q4 2023

Feb 12, 2024

BUY
$100.18 - $109.02 $6.55 Million - $7.13 Million
65,389 Added 45.78%
208,207 $22.7 Million
Q3 2023

Nov 01, 2023

BUY
$102.95 - $114.33 $3.95 Million - $4.39 Million
38,369 Added 36.73%
142,818 $14.7 Million
Q2 2023

Jul 18, 2023

SELL
$108.61 - $118.38 $21,722 - $23,676
-200 Reduced 0.19%
104,449 $12.1 Million
Q1 2023

May 15, 2023

BUY
$102.94 - $114.86 $1.46 Million - $1.63 Million
14,217 Added 15.72%
104,649 $11.1 Million
Q4 2022

Feb 14, 2023

BUY
$87.44 - $112.11 $710,362 - $910,781
8,124 Added 9.87%
90,432 $10 Million
Q3 2022

Oct 25, 2022

BUY
$84.53 - $94.96 $131,613 - $147,852
1,557 Added 1.93%
82,308 $7.09 Million
Q2 2022

Jul 21, 2022

BUY
$83.49 - $94.64 $62,617 - $70,980
750 Added 0.94%
80,751 $7.36 Million
Q1 2022

Apr 19, 2022

SELL
$73.51 - $82.4 $510,159 - $571,856
-6,940 Reduced 7.98%
80,001 $6.56 Million
Q4 2021

Feb 01, 2022

BUY
$72.28 - $90.54 $4.69 Million - $5.88 Million
64,896 Added 294.38%
86,941 $6.66 Million
Q3 2021

Oct 12, 2021

SELL
$71.68 - $78.83 $26,521 - $29,167
-370 Reduced 1.65%
22,045 $1.66 Million
Q2 2021

Jul 15, 2021

SELL
$70.31 - $77.77 $28,124 - $31,108
-400 Reduced 1.75%
22,415 $1.74 Million
Q1 2021

Apr 12, 2021

BUY
$68.86 - $81.11 $41,316 - $48,666
600 Added 2.7%
22,815 $1.76 Million
Q4 2020

Feb 09, 2021

SELL
$71.77 - $79.65 $175,118 - $194,346
-2,440 Reduced 9.9%
22,215 $1.82 Million
Q4 2019

Jan 09, 2020

SELL
$77.58 - $87.54 $163,693 - $184,709
-2,110 Reduced 7.88%
24,655 $2.24 Million
Q3 2019

Nov 06, 2019

SELL
$76.08 - $82.93 $134,433 - $146,537
-1,767 Reduced 6.19%
26,765 $2.25 Million
Q2 2019

Jul 17, 2019

SELL
$69.84 - $81.59 $12,222 - $14,278
-175 Reduced 0.61%
28,532 $2.39 Million
Q1 2019

Apr 08, 2019

SELL
$69.58 - $79.36 $113,415 - $129,356
-1,630 Reduced 5.37%
28,707 $2.39 Million
Q4 2018

Jan 24, 2019

SELL
$65.24 - $75.71 $215,618 - $250,221
-3,305 Reduced 9.82%
30,337 $2.32 Million
Q3 2018

Oct 04, 2018

SELL
$57.69 - $67.84 $53,074 - $62,412
-920 Reduced 2.66%
33,642 $2.39 Million
Q2 2018

Jul 11, 2018

SELL
$50.83 - $59.72 $29,227 - $34,339
-575 Reduced 1.64%
34,562 $2.1 Million
Q1 2018

Apr 13, 2018

BUY
$50.96 - $59.23 $746,309 - $867,423
14,645 Added 71.47%
35,137 $1.91 Million
Q3 2017

Oct 23, 2017

BUY
$58.67 - $63.13 $1.2 Million - $1.29 Million
20,492
20,492 $1.31 Million

Others Institutions Holding MRK

About Merck & Co., Inc.


  • Ticker MRK
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,533,280,000
  • Market Cap $278B
  • Description
  • Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, ...
More about MRK
Track This Portfolio

Track Mitchell Sinkler & Starr Portfolio

Follow Mitchell Sinkler & Starr and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Mitchell Sinkler & Starr, based on Form 13F filings with the SEC.

News

Stay updated on Mitchell Sinkler & Starr with notifications on news.